Gastroenterology
Volume 133, Issue 1 , Pages 312-339 , July 2007

American Gastroenterological Association Consensus Development Conference on the Use of Biologics in the Treatment of Inflammatory Bowel Disease, June 21–23, 2006

  • Michael Clark

      Affiliations

    • Department of Pathology, Cambridge University, Cambridge, England
    • ,
  • Jean-Frederic Colombel

      Affiliations

    • Clin Des Maladies De L Apparei, Hopital Huriez Chru, Lille, France
    • ,
  • Brian C. Feagan

      Affiliations

    • Robarts Clinical Trials, London, England
    • ,
  • Richard N. Fedorak

      Affiliations

    • Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Stephen B. Hanauer

      Affiliations

    • Medicine/Gastroenterology & Nutrition, The University of Chicago, Chicago, Illinois
    • Corresponding Author InformationAddress requests for reprints to: Stephen B. Hanauer, MD, and Paul Rutgeerts, MD, C/O of the AGA Institute National Office, 4930 Del Ray Avenue, Bethesda, Maryland 20814. Fax: (301) 654-5920.
    • ,
  • Michael A. Kamm

      Affiliations

    • St. Mark’s Hospital, Harrow, England
    • ,
  • Lloyd Mayer

      Affiliations

    • Center for Immunology, Mount Sinai Medical Center, New York, New York
    • ,
  • Carol Regueiro

      Affiliations

    • Freelance Medical Writer, Pittsburgh, Pennsylvania
    • ,
  • Paul Rutgeerts

      Affiliations

    • University Hospital Gasthuisberg, Leuven, Belgium
    • ,
  • William J. Sandborn

      Affiliations

    • IBD Interest Group, Mayo Clinic, Gastroenterology and Hepatology, Rochester, Minnesota
    • ,
  • Bruce E. Sands

      Affiliations

    • Clinical Research, Massachusetts General Hospital, Andover, Massachusetts
    • ,
  • Stefan Schreiber

      Affiliations

    • Department of General Internal Medicine, Christian-Albrechts-University, Kiel, Germany
    • ,
  • Stephan Targan

      Affiliations

    • Division of Gastroenterology & IBD Center, Cedars-Sinai Medical Center, Los Angeles, California
    • ,
  • Simon Travis

      Affiliations

    • John Radcliffe Hospital, Gastroenterology Unit, Oxford, England
    • ,
  • Severine Vermeire

      Affiliations

    • University Hospital Gasthuisberg, Leuven, Belgium

 Participants in the conference have indicated they have the following financial relationships with companies that market drugs and devices to gastroenterologists:

Michael Clark, PhD—Consultant: BioTie Therapies Corp, BTG Plc, Cambridge University Technical Services (CUTS) Ltd, Celltech Therapeutics Ltd, Centocor, Inc

Jean-Frederic Colombel, MD—Consultant: Boehringer-Ingelheim, Otsuka Pharmaceuticals, Protein Design Labs, Gruenenthal GMBH, Pharmion, UCB Pharmaceuticals/Celltech Therapeutics Ltd, Berlex/Schering-Plough, Centocor, Inc, Schering-Plough Corp, Elan Pharmaceuticals, Abbott Laboratories; Lectures: Centocor, Inc, Schering-Plough Corp, Abbott Laboratories, Elan Pharmaceuticals, Ferring USA; Grant Support: Giuliani, AstraZeneca Pharmaceuticals, Ferring USA, Danisco, Sanofi, Ferring France

Brian C. Feagan, MD—Grant/Research Support: Schering-Plough Corp, Otsuka Pharmaceuticals, Millenium Pharmaceuticals, Tillotts, Abbott Laboratories, Protein Design Labs, Boehringer-Ingelheim, Novartis, Centocor, Inc, Berlex; Consultant: Synta Pharmaceuticals, Millenium Pharmaceuticals, Schering Canada, Celltech Therapeutics Ltd, Centocor, Inc, Elan/Biogen, Serono, Janssen-Ortho, Protein Design Labs, Isis, Teva Pharmaceuticals, Santarus, Inc, Schering-Plough Corp; Speakers’ Bureau: AstraZeneca Pharmaceuticals; Member, Scientific Advisory Board: Protein Design Labs, AstraZeneca Pharmaceuticals, Elan/Biogen, Celltech, Synta Pharmaceuticals, Schering Canada; Stock Shareholder: Santarus, Inc

Richard N. Fedorak, MD—Consultant, Speakers’ Bureau, or Grant Funding: Abbott, Schering, Elan, USB, BMS, Centocor

Stephen B. Hanauer, MD—Consultant: Centocor, Abbott Laboratories, UCB Pharma, Elan Pharmaceuticals, PDL Biopharma, Millenium Pharmaceuticals, Berlex Laboratories, Bristol-Meyers-Squibb; Research Support: Centocor, Abbott Laboratories, UCB Pharma, Elan Pharmaceuticals, PDL Biopharma, BMS; Lecture Honorarium: Centocor, Abbott Laboratories, UCB Pharma, Elan Pharmaceuticals, PDL Biopharma

Michael A. Kamm, MD, PhD—Consultant: Abbott, Elan, Schering-Plough, UCB

Lloyd Mayer, MD—Consultant: Centocor, Inc, Abbott Laboratories, Protein Design Labs, Prometheus Labs, Salix

Carol Regueiro, MD—No financial relationships to disclose.

Paul Rutgeerts, MD—Speakers’ Bureau: Biogen Idec, Centocor, Inc, Elan Pharmaceuticals, Schering-Plough Corp; Advisor: Centocor, Inc, Schering-Plough Corp; Consultant: Millenium Pharmaceuticals, Protein Design Labs, Centocor, Schering-Plough, UCB Pharma, Abbott Laboratories, Bristol-Myers Squibb; Research support: Centocor, Schering-Plough, Abbott, UCB; Lecture honorarium: Centocor, Inc, Schering-Plough Corporation, UCB Pharma, Abbott Laboratories, Protein Design Labs.

William J. Sandborn, MD—Research Support: Centocor, Abbott Laboratories, UCB Pharma, Elan Pharmaceuticals, PDL Biopharma; Consultant: Centocor, Abbott Laboratories, UCB Pharma, Elan Pharmaceuticals, PDL Biopharma, Millenium Pharmaceuticals, Cerimon Pharmaceuticals, Isis Pharmaceuticals, Berlex Laboratories; Continuing Medical Education Unrestricted Grants: Centocor Abbott Laboratories, UCB Pharma, Elan Pharmaceuticals, PDL Biopharma

Bruce E. Sands, MD—Consultant: Centocor, Biogen/IDEC, Elan, Abbott Laboratories, Prometheus Laboratories, Shire Pharmaceuticals, Berlex, Protein Design Laboratories Biopharma, Otsuka America Pharmaceuticals Inc, Solvay Pharmaceuticals, Procter & Gamble Pharmaceuticals, Synta Pharmaceuticals, Avidia, Cerimon Pharmaceuticals, Bristol-Myers Squibb, Osiris, Millenium Pharmaceuticals; Research Support: Centocor, Elan, Abbott Laboratories, Prometheus Laboratories, Berlex, Otsuka, Synta Pharmaceuticals, Millenium Pharmaceuticals; Lectures: Centocor, Abbott Laboratories, Shire Pharmaceuticals, Berlex, Otsuka America Pharmaceuticals Inc, Procter & Gamble Pharmaceuticals

Stefan Schreiber, MD—Grant/Research Support: Centocor, Inc, Schering-Plough Corp, UCB Pharmaceuticals; Consultant: UCB Pharmaceuticals, Schering-Plough Corp, Elan Pharmaceuticals, Abbott Laboratories, Teva Pharmaceuticals, Boehringer-Ingelheim; Major Stock Shareholder: Conan’s AG

Stephan Targan, MD—Consultant: Scientific Advisory Board, Santarus, Inc, Protein Design Labs; Major Stock Shareholder: Prometheus Labs, Santarus, Inc; Other: Member, Board of Directors, Prometheus Labs

Simon Travis, MD—Adviser, Lecturer, Unrestricted Educational Grants, or Research Support: Abbott, Centocor, Schering Plough, UCB

Severine Vermeire, MD, PhD—Grants/Research Support: UCB; Consultancy: Astra-Zeneca, Ferring; Speakers’ Bureau: Schering-Plough, Abbott, Ferring, UCB; Advisory Committee: Shire, Ferring

PII: S0016-5085(07)00988-2

doi: 10.1053/j.gastro.2007.05.006

Gastroenterology
Volume 133, Issue 1 , Pages 312-339 , July 2007

Article Tools

* Image Usage & Resolution